Related Experiment Video
Updated: Sep 19, 2025

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
Published on: July 2, 2013
Unlocking Enhanced Efficacy of Aminoglycoside Antibiotics Against Pseudomonas aeruginosa
Patrick Ofori Tawiah1, Sadia Sultana1, Jan-Ulrik Dahl1
1School of Biological Sciences, Microbiology, Illinois State University, Normal, Illinois, USA.
Abstract:
Infectious diseases continue to be a global health burden. Among the major human pathogens is the Gram-negative bacterium Pseudomonas aeruginosa, which is particularly due to its wide range of drug resistance mechanisms. Aminoglycosides, which have long been used in treating pseudomonal infections, are increasingly undermined by resistance. This opinion article discusses the use and challenges of aminoglycosides against P. aeruginosa and highlights recent strategies that enhance aminoglycoside efficacy. These include combinational therapies, metabolic stimulants/adjuvants, silver, and more recently developed derivatives such as AGXX, many of which have been reported to potentiate the cytotoxic effects of aminoglycosides and re-sensitise aminoglycoside-resistant strains. While these findings pave the way for future therapies, the clinical relevance of many in vitro studies remains to be investigated.
Insights
Aminoglycoside antibiotics face resistance from Pseudomonas aeruginosa infections. New strategies like combination therapies and novel derivatives (e.g., AGXX) show promise in overcoming this resistance and restoring drug efficacy.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Pseudomonas aeruginosa is a significant Gram-negative pathogen causing global health issues.
- Increasing aminoglycoside resistance in P. aeruginosa limits treatment options for pseudomonal infections.
Purpose of the Study:
- To discuss the current use and challenges of aminoglycosides against P. aeruginosa.
- To highlight emerging strategies for enhancing aminoglycoside efficacy.
Main Methods:
- Review of existing literature on aminoglycoside resistance in P. aeruginosa.
- Analysis of novel therapeutic strategies, including combinational therapies, metabolic stimulants, silver, and AGXX derivatives.
Main Results:
- Several strategies, including combinational therapies and AGXX, demonstrate potential to potentiate aminoglycoside effects.
- These approaches may re-sensitize P. aeruginosa strains resistant to aminoglycosides.
Conclusions:
- Emerging strategies offer promising avenues for combating aminoglycoside-resistant P. aeruginosa infections.
- Further in vitro studies require clinical validation to assess real-world therapeutic relevance.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Effectiveness